Europe Liver Cancer Therapeutics Market to Reach at High CAGR of 8.95% by 2023-2030
The liver cancer therapeutics market in Europe is rapidly growing due to an increasing incidence of liver cancer in the region. Liver cancer, also known as hepatocellular carcinoma, is one of the most common types of cancer globally, with Europe being no exception. According to recent estimates, the incidence of liver cancer in Europe is expected to increase significantly in the coming years.
View full press release